Identification of a New Function of Cardiovascular Disease Drug 3-Morpholinosydnonimine Hydrochloride as an Amyloid-β Aggregation Inhibitor

[Image: see text] Cardiovascular disease (CVD) and Alzheimer’s disease (AD) have a mutual cause-and-effect relationship, and they share some common risk factors. Although numerous Food and Drug Administration (FDA)-approved drugs have been developed for CVD treatment, no drugs are clinically availab...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Baiping, Zhang, Mingzhen, Hu, Rundong, Chen, Hong, Wang, Manli, Lin, Yufeng, Sun, Yan, Jia, Lingyun, Liang, Guizhao, Zheng, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044715/
https://www.ncbi.nlm.nih.gov/pubmed/30023514
http://dx.doi.org/10.1021/acsomega.6b00397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044715/
https://www.ncbi.nlm.nih.gov/pubmed/30023514
http://dx.doi.org/10.1021/acsomega.6b00397

Ejemplares similares